Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluarix immunogenicity and safety in children previously vaccinated with Pandemrix
NL-OMON34465Phase 4Active, not recruiting
- Sponsor
- GSK
- Start
- Sep 2010
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Fluarix in influenza (2 arms), sponsored by GSK. Primary endpoint: Humoral immune response against H1N1 in the Fluarix group. Started Sep 2010; status: active, not recruiting.
02
Drugs
Fluarix
03
Conditions
influenza
Beyond the preview
Go deeper on NL-OMON34465.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34465.